Barnstable Covid-19 Outbreak: Fully Vaccinated Can Spread Coronavirus Delta Variant, Says CDC

74% of the SARS-CoV2 infections were in fully vaccinated persons. This doesn't mean that the Covid-19 don't offer protection but it means that Covid-19 vaccines alone may not be enough right now.
Source: Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

Related Links:

This report describes an outbreak with the Delta variant in a federal Texas prison among unvaccinated and vaccinated persons.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report Outbreaks SARS (Severe acute respiratory syndrome) Vaccination Vaccines COVID-19 Source Type: news
samonti An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) started in December 2019 in China and then become pandemic in February 2020. Several publications investigated the possible increased rate of COVID-19 infection in hematological malignancies. Based on the published data, strategies for the management of chronic Philadelphia-negative chronic myeloproliferative neoplasms (MPNs) are provided. The risk of severe COVID-19 seems high in MPN, particularly in patients with essential thrombocythemia, but not negligible in myelofibrosis. MPN patients are at high risk of both thrombotic and hemorrh...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
The rapid outbreak of COVID-19 caused by the novel coronavirus SARS-CoV-2 in Wuhan, China, has become a worldwide pandemic affecting almost 204 million people and causing more than 4.3 million deaths as of August 11 2021. This pandemic has placed a substantial burden on the global healthcare system and the global economy. Availability of novel prophylactic and therapeutic approaches are crucially needed to prevent development of severe disease leading to major complications both acutely and chronically. The success in fighting this virus results from three main achievements: (a) Direct killing of the SARS-CoV-2 virus; (b) ...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
This article reviews what is known about the humoral and cellular immune responses to SARS-CoV-2 and how mutation and structural/functional changes in the emerging variants of concern impact upon the immune protection from prior infection or vaccination.
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
Tahmina Shirin Diverse coronavirus (CoV) strains can infect both humans and animals and produce various diseases. CoVs have caused three epidemics and pandemics in the last two decades, and caused a severe impact on public health and the global economy. Therefore, it is of utmost importance to understand the emergence and evolution of endemic and emerging CoV diversity in humans and animals. For diverse bird species, the Infectious Bronchitis Virus is a significant one, whereas feline enteric and canine coronavirus, recombined to produce feline infectious peritonitis virus, infects wild cats. Bovine and canine CoVs ha...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
ka Since its outbreak in December 2019, the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to an enormous rise in scientific response with an excess of COVID-19-related studies on the pathogenesis and potential therapeutic approaches. Solid organ transplant (SOT) recipients are a heterogeneous population with long-lasting immunosuppression as a joining element. Immunocompromised patients are a vulnerable population with a high risk of severe infections and an increased infection-related mortality rate. It was postulated that the hyperinflammator...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
Conclusions: In summary, our data show that partial vaccination prevented severe COVID-19 among the residents during this local SARS-CoV-2 outbreak, suggesting a high effectiveness of even a single vaccine dose, but also emphasize that asymptomatic individuals might still be carriers/spreaders. AbstractBackground: A total of 62/66 (93.9%) residents in a senior citizen home in Bremen, Germany, received the first dose of the Biontech/Pfizer vaccine BNT162b2 on December 27th 2020. After routine severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen tests showed positive results on January 5th, all residents and ...
Source: Immunity, Inflammation and Disease - Category: Allergy & Immunology Authors: Tags: SHORT REPORT Source Type: research
Trop Biomed. 2021 Sep 1;38(3):343-352. doi: 10.47665/tb.38.3.077.ABSTRACTOutbreak of SARS-CoV-2 has been declared a pandemic, which is a serious threat to human health. The disease was named coronavirus disease 2019 (COVID-19). Until now, several vaccines and a few drugs have been approved for the prevention and treatment for COVID-19. Recently, the effect of some macrolides including clarithromycin (CAM) on COVID-19 has attracted attention. CAM is known to have diverse effects including immunomodulatory and immunosuppressive effects, autophagy inhibition, steroid sparing effect, reversibility of drug resistance, antineopl...
Source: Tropical Biomedicine - Category: Tropical Medicine Authors: Source Type: research
ConclusionsOur data show that individuals who got infected as early as 10 days after their first immunization show antibody levels comparable to fully vaccinated individuals.
Source: Immunity, Inflammation and Disease - Category: Allergy & Immunology Authors: Tags: ORIGINAL ARTICLE Source Type: research
Viruses, Vol. 13, Pages 1768: Nafamostat–Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2 Viruses doi: 10.3390/v13091768 Authors: Aleksandr Ianevski Rouan Yao Hilde Lysvand Gunnveig Grødeland Nicolas Legrand Valentyn Oksenych Eva Zusinaite Tanel Tenson Magnar Bjørås Denis E. Kainov SARS-CoV-2 and its vaccine/immune-escaping variants continue to pose a serious threat to public health due to a paucity of effective, rapidly deployable, and widely available treatments. Here, we address these challenges...
Source: Viruses - Category: Virology Authors: Tags: Brief Report Source Type: research
More News: Coronavirus | COVID-19 | Outbreaks | Pharmaceuticals | SARS | Science | Vaccines